INTRODUCTION
The indications for laparoscopic liver resection have been widening, even for cancer treatment options [1] .
However, laparoscopic liver resection has various efficacy and safety concerns for the procedure, and gas emboli and appropriate bleeding control are technical problems [2] .
Second, port-site implantations and tumor cell seeding under a CO2 pneumoperitoneum are of concern to surgeons [2] . However, accumulating data have revealed that these problems have been overcome [3] , and laparoscopic liver resection for hepatocellular carcinoma (HCC) seems to offer advantages over conventional open surgery in terms of shortened postoperative recovery [4] [5] [6] [7] [8] [9] , immunological benefits [10] , and smaller volumes of ascites [3, 5] .
However, most of these studies have reported typically minor hepatic procedures with tumor locations in peripheral liver segments (segments 2 to 6), and few were comparative [3, 4, 7, 11] . Additionally, the oncological results of laparoscopic liver resection for HCC remain a matter of 
Indication for a laparoscopic liver resection
According to the international consensus meeting on laparoscopic liver surgery [12] , the best indication for a laparoscopic liver resection is a patient with solitary lesions and tumors sized 5 cm or smaller and located in peripheral liver segments (segments 2 to 6). Our indications for a laparoscopic procedure were tumors 5 cm or less in size, no major vascular invasion (e.g., main portal vein or main hepatic vein) regardless of the location of the tumor, an ASA score ＜4, and disease-free margins. Other indications were the same as for an open liver resection. One case with an 8-cm sized mass underwent a laparoscopic operation and was included in this study. The tumor was located in the periphery and had no major vascular invasion. Thus, it was thought that an adequate disease-free margin could be achieved.
Laparoscopic liver resection surgical procedure
All operations were performed under general anesthesia. A pneumoperitoneum was established using CO2 gas and then maintained below 10 mmHg to prevent a gas embolism. Laparoscopic ultrasonography was routinely used to localize tumors and to demonstrate satellite nodules. Patient position, trochar placement, and type of resection were determined according to tumor location. A Harmonic scalpel (Ethicon Endo-Surgery Inc, Cincinnati, OH, USA) was primarily applied for the parenchymal transection. An anatomically major liver resection was usually performed using an intrafascial or extrahepatic approach. The portal pedicles were dissected outside the liver parenchyma, and the portal branch, the arterial branch, and the bile duct were separated. The arterial and portal branches were clipped and divided. When the portal branch was too large to apply clips, it was divided with a linear stapler. The Pringle maneuver was not performed.
The resected specimen was inserted into a plastic bag, and retrieved through an extended epigastric port site incision. After meticulous hemostasis, a fibrin glue sealant (Greenplast, Green Cross Co., Seoul, Korea) was sprayed on the cut surfaces. After irrigation, a closed suction drain was inserted, and the wound was closed in layers.
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Outcome measures
The following operative variables were collected for each patient: demographics, tumor location and histology, size of hepatic lesions, operative details, morbidity, most recent follow-up data, disease-free status (e.g., recurrence
vs. non-recurrence), and date of recurrence. Morbidity and postoperative hospital stay were evaluated according to the Clavien complication grading system [13, 14] . Discharge criteria were the ability to tolerate a soft or regular hospital diet and pain control with oral analgesics.
After discharge, all patients were followed with a surveillance protocol that included a multislice computed tomography scan, liver function tests, and serum alpha-fetoprotein level every 3 months after resection for 2 years, then every 4 to 6 months.
Disease-free survival was calculated from the date of the operation to the date of recurrence or last follow-up.
Statistical analyses
Summary statistics are reported using mean or median values, where appropriate. The Student's t-test and MannWhitney U-test were used for the mean comparison of continuous variables and for ordinal data, respectively, whereas the chi-squared and Fisher exact tests were used to compare frequencies of categorical variables between groups. Survival rates were calculated using the KaplanMeier method, and survival curves were compared using the log-rank test. Significance was defined as P ≤ 0.05. All statistical analyses were performed using the SPSS ver.
14.0 (SPSS Inc., Chicago, IL, USA).
RESULTS
Clinicopathological features and tumor characteristics are summarized in Table 1 . Additional parameters, such as transaminase levels, total bilirubin, and prothrombin time, were similar between the L-and O-groups.
Intraoperative clinical outcomes
The intraoperative clinical outcomes are summarized in Open liver resection group. The size of the skin incision in the L-group was 6 to 7 cm for the major (≥3 segments) liver resection hepatectomies and ＜5 cm for the minor (＜3 segments) resections, which was shorter than that in the O-group (about 10 to 15 cm).
Postoperative clinical outcomes
We compared the postoperative clinical outcomes between the two groups (Table 3) Open liver resection group. 
Follow-up and disease-free survival
Follow-up and survival are summarized in Table 4 (Fig. 1 ).
In the L-group, recurrence were treated by further surgery (2 patients), transarterial chemoembolization (transarterial chemoembolization [TACE]; 2), radio-frequency ablation (radiofrequency ablation [RFA]; 2), and refusal of any form of therapy [1] , while patients with a recurrence were treated by re-resection [1] , TACE [4] , RFA [2] , radiotherapy [1] , and refusal of any form of therapy [2] in the O-group.
No patients died in the L-group, whereas three patients died in the O-group, and median overall survival was 25.6 months (range, 3.6 to 59.4 months).
DISCUSSION
Since the first report of laparoscopic liver resection by Gagner et al. [16] in 1992, an increasing number of small prospective studies have been published. These studies have reported encouraging results for the feasibility and safety of the procedure. Laparoscopic resection has been more frequently proposed as a curative treatment for HCC [3, [6] [7] [8] 11, [17] [18] [19] or as a preliminary treatment before transplantation [20] .
However, laparoscopic liver resection for HCC is still challenging for both surgeons and patients, because most HCCs are associated with underlying liver disease, such as chronic hepatitis and liver cirrhosis. Moreover, applying laparoscopic resection to HCC has been limited by tumor location. Most reported cases had peripheral lesions located in the anterolateral segments (segments 2, 3, 4b, 5, and 6) [3, 7, [17] [18] [19] 21] . Additionally, major liver resections (i.e., right or left hemihepatectomies) are feasible, but remain difficult procedures that should be reserved for experienced surgeons [12] . In our study, tumor location in Aldrighetti et al. [4] reported that the laparoscopic ap- 16.1 days, P = 0.034).
The main concern with using the laparoscopic technique for malignancies is the risk of inadequate tumor resection. However, no difference has been observed in margin-free resections between laparoscopic and open liver resection in many comparative studies [3, [5] [6] 9, 12, [23] [24] [25] [26] . In our series, one case in each group had tumor exposure at the surgical specimen surface (R1 resection); this was not significant (P = 1.000).
Another concern about laparoscopic resection of malignancies is the risk for a port-site tumor recurrence, which was not recorded in our patients. With more than 3,000
cases of minimally invasive hepatic resection in the literature, no incidence of port-site recurrence or tumor seeding has been reported [3] [4] [5] [6] [7] [8] 22] . Thus, this concern should not prevent surgeons from conducting a laparoscopic approach.
Both groups underwent surgery performed by the same surgeon, confirming the feasibility and safety of the lapa- These results are comparable with the results of other studies showing an overall 3-year survival of 60 to 93%, and 3-year disease-free survival of 52 to 64% after laparoscopic liver resection for HCC [11, 18, 19] . In our study, In conclusion, the present study showed that laparoscopic liver resection for HCC is feasible and safe in se- 
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